Trends Pharmacol Sci. 1992 Nov;13(11):413-7.

Development of GPIIb/IIIa antagonists as antithrombotic drugs.

Nichols AJ, Ruffolo RR Jr, Huffman WF, Poste G, Samanen J.

Source

Smith-Kline Beecham Pharmaceuticals, King of Prussia, PA 19406.

Abstract

Thrombosis represents a major target for development of drugs to prevent and treat a variety of cardiovascular and cerebrovascular diseases, which are the leading cause of morbidity and mortality in the Western world. This review by Andy Nichols and colleagues focuses on a central process in thrombosis, namely platelet aggregation, and how it can be inhibited by antagonists of the adhesion molecule GPIIb/IIIa. Successful and future therapeutic applications of GPIIb/IIIa antagonists, and their pharmacology, are considered in detail.

PMID:: 1440877; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

COS Scholar Universe

Medical

Blood Thinners - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model. [Blood. 1992]
Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D. Blood. 1992 Sep 1; 80(5):1247-53.
Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. [Circulation. 1994]
Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA, Bozarth JM, Forsythe MS, Jackson SM, Leamy A, Diemer MM, Kapil RP, Knabb RM, Mayo MC, Pierce SK. Circulation. 1994 Jan; 89(1):3-12.
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. [J Cardiovasc Pharmacol. 1997]
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH. J Cardiovasc Pharmacol. 1997 Aug; 30(2):261-72.
Review Novel antithrombotic drugs in development. [Drugs. 1995]
Review Novel antithrombotic drugs in development.
Verstraete M, Zoldhelyi P. Drugs. 1995 Jun; 49(6):856-84.
Review Antithrombotic agents: from RGD to peptide mimetics. [Bioorg Med Chem. 1995]
Review Antithrombotic agents: from RGD to peptide mimetics.
Ojima I, Chakravarty S, Dong Q. Bioorg Med Chem. 1995 Apr; 3(4):337-60.

See reviews... See all...

Cited by 3 PubMed Central articles

Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species. [Biochem J. 1995]
Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species.
Chen YL, Huang TF, Chen SW, Tsai IH. Biochem J. 1995 Jan 15; 305 ( Pt 2):513-20.
Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. [Biochem J. 1995]
Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen.
Zhou Q, Smith JB, Grossman MH. Biochem J. 1995 Apr 15; 307 ( Pt 2):411-7.
Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa. [Biochem J. 1994]
Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.
Satoh T, Kouns WC, Yamashita Y, Kamiyama T, Steiner B. Biochem J. 1994 Aug 1; 301 ( Pt 3):785-91.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Development of GPIIb/IIIa antagonists as antithrombotic drugs.
Development of GPIIb/IIIa antagonists as antithrombotic drugs.
Trends Pharmacol Sci. 1992 Nov ;13(11):413-7.

PubMed
Value of equivocal signs in neurologic diagnosis.
Value of equivocal signs in neurologic diagnosis.
Neurology. 1960 Aug ;10:753-64.

PubMed
Corneal ulceration in Tanzanian children: relationship between measles and vitam...
Corneal ulceration in Tanzanian children: relationship between measles and vitamin A deficiency.
Trans R Soc Trop Med Hyg. 1992 Jul-Aug ;86(4):454-5.

PubMed
[Genetic heterogeneity of G6PD deficiency: mutant alleles of G6PD in the Shekii ...
[Genetic heterogeneity of G6PD deficiency: mutant alleles of G6PD in the Shekii district of Azerbaijan].
Genetika. 1977 ;13(8):1455-61.

PubMed
Fractures of the forearm in adults.
Fractures of the forearm in adults.
South Med J. 1960 Jun ;53:669-79.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: